
Over the last 7 days, the Healthtech industry has risen 3.0%, driven by gains from Craneware of 3.7%. In the same time, Shortwave Life Sciences was down 8.6%. Despite this gain, the industry's performance has been flat over the past year. Looking forward, earnings are forecast to grow by 19% annually.
Has the U.K. Healthtech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 14 Jan 2026 | UK£892.8m | UK£280.9m | UK£8.9m | 48.9x | 99.9x | 3.2x |
| Fri, 12 Dec 2025 | UK£870.2m | UK£281.0m | UK£8.9m | 47.7x | 97.3x | 3.1x |
| Sun, 09 Nov 2025 | UK£957.8m | UK£275.4m | UK£7.4m | 78.7x | 130.1x | 3.5x |
| Tue, 07 Oct 2025 | UK£1.1b | UK£271.6m | UK£2.5m | 88.8x | 422.2x | 3.9x |
| Thu, 04 Sep 2025 | UK£972.5m | UK£266.8m | UK£3.1m | 93.4x | 318.8x | 3.6x |
| Sat, 02 Aug 2025 | UK£994.8m | UK£270.1m | UK£2.9m | 90.6x | 343.1x | 3.7x |
| Mon, 30 Jun 2025 | UK£943.4m | UK£265.0m | -UK£600,258.00 | 67.8x | -1571.6x | 3.6x |
| Wed, 28 May 2025 | UK£914.5m | UK£280.0m | -UK£3,891,971.75 | 64.5x | -235x | 3.3x |
| Fri, 25 Apr 2025 | UK£753.0m | UK£284.6m | -UK£3,556,332.00 | 49.8x | -211.7x | 2.6x |
| Sun, 23 Mar 2025 | UK£841.3m | UK£289.4m | -UK£3,195,167.00 | 55x | -263.3x | 2.9x |
| Tue, 18 Feb 2025 | UK£981.0m | UK£301.2m | -UK£8,814,265.25 | 78.9x | -111.3x | 3.3x |
| Thu, 16 Jan 2025 | UK£933.8m | UK£300.9m | -UK£8,739,235.33 | 76x | -106.8x | 3.1x |
| Sat, 14 Dec 2024 | UK£1.0b | UK£295.8m | -UK£9,054,046.03 | 88.4x | -112.8x | 3.5x |
| Mon, 11 Nov 2024 | UK£945.6m | UK£298.5m | -UK£4,049,509.15 | 47x | -233.5x | 3.2x |
| Wed, 09 Oct 2024 | UK£897.6m | UK£297.1m | -UK£4,152,136.89 | 43.4x | -216.2x | 3x |
| Fri, 06 Sep 2024 | UK£869.9m | UK£185.4m | -UK£3,117,470.28 | 50.5x | -279x | 4.7x |
| Sun, 04 Aug 2024 | UK£897.4m | UK£184.2m | -UK£6,058,638.84 | 61.9x | -148.1x | 4.9x |
| Tue, 02 Jul 2024 | UK£877.3m | UK£184.2m | -UK£16,895,938.76 | 60.2x | -51.9x | 4.8x |
| Thu, 30 May 2024 | UK£873.2m | UK£182.7m | -UK£17,163,829.40 | 60x | -50.9x | 4.8x |
| Sat, 27 Apr 2024 | UK£837.4m | UK£184.2m | -UK£17,503,089.40 | 56.1x | -47.8x | 4.5x |
| Mon, 25 Mar 2024 | UK£868.6m | UK£183.1m | -UK£17,560,771.64 | 56.5x | -49.5x | 4.7x |
| Wed, 21 Feb 2024 | UK£823.6m | UK£174.3m | -UK£17,190,907.48 | 101.4x | -47.9x | 4.7x |
| Fri, 19 Jan 2024 | UK£2.2b | UK£419.8m | -UK£18,252,467.00 | 59.8x | -118.9x | 5.2x |
| Sun, 17 Dec 2023 | UK£2.2b | UK£420.0m | -UK£18,238,711.00 | 59.8x | -117.9x | 5.1x |
| Tue, 14 Nov 2023 | UK£2.1b | UK£427.4m | -UK£55,177,386.00 | 56.8x | -38.8x | 5x |
| Thu, 12 Oct 2023 | UK£2.1b | UK£428.0m | -UK£57,501,541.00 | 56.1x | -36.1x | 4.9x |
| Sat, 09 Sep 2023 | UK£2.1b | UK£423.3m | -UK£47,140,090.00 | 40.2x | -45.6x | 5.1x |
| Mon, 07 Aug 2023 | UK£1.8b | UK£415.5m | -UK£44,239,149.00 | 30.7x | -40.4x | 4.3x |
| Wed, 05 Jul 2023 | UK£1.7b | UK£413.4m | -UK£34,961,288.00 | 30.5x | -49.2x | 4.2x |
| Fri, 02 Jun 2023 | UK£1.7b | UK£414.3m | -UK£38,739,163.00 | 51.7x | -43.4x | 4.1x |
| Sun, 30 Apr 2023 | UK£1.9b | UK£405.5m | -UK£46,408,266.00 | 71.1x | -40.3x | 4.6x |
| Tue, 28 Mar 2023 | UK£1.9b | UK£408.2m | -UK£48,623,822.00 | 68x | -39.3x | 4.7x |
| Thu, 23 Feb 2023 | UK£2.1b | UK£407.0m | -UK£48,530,381.00 | 72.1x | -43.5x | 5.2x |
| Sat, 21 Jan 2023 | UK£2.1b | UK£403.1m | -UK£47,445,833.00 | 76x | -44.5x | 5.2x |
-44.5x
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | 0.19% | |
| Healthcare | -1.04% | |
| Healthtech | 3.00% | |
| Healthtech | 3.00% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CRW Craneware | UK£19.80 | 3.7% +UK£24.6m | -5.3% | PE47.4x | |
| RENX Renalytix | UK£0.063 | 5.9% +UK£1.5m | -47.9% | PS12.2x | |
| OPT Optima Health | UK£2.00 | 0.5% +UK£887.8k | 42.3% | PE50.3x | |
| FDBK Feedback | UK£0.13 | 12.3% +UK£613.4k | -35.6% | PS6.3x |